Skip to NavigationSkip to content

Ebola

EU and drug industry set aside €280m for Ebola

Ebola image
Ebola vaccine

The EU's Innovative Medicines Initiative (IMI) has unveiled a new programme to find vaccines, drugs and diagnostics for Ebola, funded to the tune of €280 million.

The IMI - which operates as a partnership between the European Commission and the pharmaceutical industry - says it is now seeking proposals for projects that "will help make a difference in the current and future outbreaks". 

The money brings the total investment by the EU into tackling Ebola to €805 million, with DG Sanco pledging €525 million to the cause earlier this year.

J&J announces ‘major commitment’ to Ebola effort

J&J image

Johnson & Johnson will invest $200 million to accelerate and significantly expand the production of its Ebola vaccine programme.

The company says it is closely collaborating with the World Health Organization (WHO), the National Institute of Allergy and Infectious Diseases (NIAID), as well as other key stakeholders on the development of the treatment.

GSK: Ebola vaccines will come ‘too late’

Ebola image

GlaxoSmithKline says its potential Ebola vaccine will come ‘too late’ for the current outbreak despite being fast-tracked.

In August the company said that trials would begin soon, with the vaccine rolled-out by 2015 if everything went to plan. But today in a TV and radio interview with the BBC, Dr Ripley Ballou who is the head of GSK's Ebola vaccine research says that it will ‘well into 2016’ before they would be able to manufacture the amount required.

Chinese military-linked firm says it has Ebola cure

Colorised transmission electron micrograph of Ebola virus virion
Colorized transmission electron micrograph of Ebola virus virion

A Chinese drugmaker that has close military ties is seeking fast-track approval for its JK-05 drug that it says can cure Ebola.

Sihuan Pharmaceutical Holdings partnered with the Chinese research Academy of Military Medical Sciences (AMMS) in October, to help push the drug through the Chinese Food and Drug Administration’s approval processes quickly.

Texas Ebola victim dies as diseases spreads

Ebola image
WHO has reported 8,033 Ebola cases, with 3,865 deaths in six countries

A Liberian national named Thomas Eric Duncan has died in an isolation ward of a Dallas, Texas hospital after being admitted 11 days before.

Duncan flew into the US in late September from his home country of Liberia to visit family, but after initially showing no symptoms he became very ill. His condition was not immediately picked up however, and Duncan initially sought treatment two days before being admitted, but was sent home with antibiotics.

J&J fast-track Ebola vaccine for early 2015 trials

Ebola Africa
Health workers in Africa are trying to slow the spread of the virus

Johnson & Johnson has announced it is to fast-track the development of a new vaccine programme to fight the deadly haemorrhagic virus Ebola that is currently sweeping across Africa.

The firm says that it will collaborate with its partners in global health to provide relief and to address the current Ebola outbreak, which has now killed 1,900 people according to the World Health Organization (WHO), mainly in West Africa.

The experimental vaccine features a so-called prime-boost regimen in which one vector is used to prime and the other to boost the immune response.

GSK Ebola vaccine fast-tracked into human trials

GSK image

GlaxoSmithKline has announced that its experimental Ebola vaccine is being fast-tracked into human studies to help deal with the worst-ever outbreak of the virus.

The London-based firm says its research into the vaccine, which has currently only been tested in animals, was being accelerated with funding from an international consortium.

The company also plans to build up a stockpile of up to 10,000 doses for emergency deployment, if results from the studies are deemed good enough.

UK nurse with Ebola given new drug in London

WHO Ebola
An Ebola patient recieves care from healthcare workers in Africa

A British nurse was this weekend flown to a London hospital and is now being given an experimental drug after contracting the Ebola disease during his time volunteering in West Africa.

William Pooley, a volunteer nurse at The Shepherd’s Hospice in Sierra Leone, is the first confirmed case of a Briton contracting the virus that has killed almost 1,500 people.

Pooley was flown to Hampstead’s Royal Free Hospital in north-west London on Sunday in a specially equipped military aircraft.

Wellcome Trust makes Ebola research investment

Ebola image

The Wellcome Trust is launching a new multimillion pound initiative for emergency Ebola research coupled with a £40 million investment for longer-term medical research in Africa.

This comes a week after the World Health Organization said it will allow untested treatments for Ebola to be used in West Africa, as the death toll from the virus passes the 1,000 mark.

Untested Ebola drugs can be used in Africa

Ebola image

The World Health Organization will allow untested treatments for Ebola to be used in West Africa as the death toll from the virus passes the 1,000 mark.

The WHO’s panel of medical ethicists said several experimental drugs had passed the laboratory and animal study phases of development, and should be fast-tracked into clinical trials and made available for compassionate use.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches